Treatment of Essential Hypertension With Rasilez. Evaluation of Different Methods of Blood Pressure Measurements - Efficacy and Safety Evaluation.

Trial Profile

Treatment of Essential Hypertension With Rasilez. Evaluation of Different Methods of Blood Pressure Measurements - Efficacy and Safety Evaluation.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Aliskiren (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms REALITY
  • Most Recent Events

    • 09 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 06 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 11 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top